Histology and Cytology Market By Type of Examination, By Product, By Test Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

List of Tables

The global histology and cytology market was valued at $7.2 billion in 2022, and is projected to reach $22.2 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032.

Histology and cytology constitute indispensable analytical techniques in the healthcare sector, holding a pivotal significance in the diagnosis and therapeutic management of diverse medical conditions. Histology entails the microscopic examination of tissues, scrutinizing their structural characteristics and identifying anomalies, whereas cytology concentrates on the examination of individual cells to identify abnormalities or diseases. These diagnostic methodologies play a critical role in the timely identification of cancer, infectious diseases, and other pathological conditions.

The rise in prevalence of chronic diseases such as cancer and the improving healthcare infrastructure is expected to drive the growth of the histology and cytology market. For instance, according to the American Cancer Society, it was reported that in 2020, Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. The notable increase in chronic conditions, such as cancer, cardiovascular diseases, and respiratory disorders, has created a pressing need for advanced diagnostic and screening methods.

Histology and cytology procedures provide invaluable insights into the cellular and tissue-level changes associated with malignancies, aiding in accurate diagnosis and the formulation of personalized treatment strategies. Moreover, as the aging population continues to grow worldwide, there is an inherent increase in the incidence of chronic diseases, further driving the demand for histology and cytology for disease diagnosis.

In addition, surge in awareness among healthcare professionals and patients plays a crucial role in driving the demand for histological and cytological examinations, as individuals become more proactive in managing their health and seeking early detection of diseases. Patients increasingly recognize the importance of histology and cytology in diagnosing various medical conditions, including cancers and infectious diseases, which has led to a rising demand for these diagnostic technologies. Moreover, healthcare professionals have become more aware of the benefits of histology and cytology in providing accurate and timely diagnoses. With advancements in medical research and technology, healthcare professionals are better equipped to understand the significance of these diagnostic tools and incorporate them into their clinical practices. Thus, the rise in awareness among the healthcare professionals and patients is expected to drive the growth of the market.

Furthermore, the improving healthcare infrastructure in developing countries is expected to drive the growth of the market. As countries across the developing regions progressively invest in upgrading their healthcare systems, there is a surge in demand for advanced diagnostic techniques, such as histology and cytology, which play a crucial role in disease detection and management. For instance, according to the 2023 report by National Library of Medicine, it was reported that over two lakh public health facilities were reported in India as of the financial year 2022. The expansion and modernization of healthcare facilities, including hospitals, diagnostic laboratories, and research centers, are creating a robust ecosystem for the adoption of cutting-edge histology and cytology technologies. Thus, the improving healthcare infrastructure is expected to significantly contribute to the growth of the market.

The histology and cytology market is segmented on the basis of type of examination, product, test type, application, end user, and region. On the basis of type of examination, the market is bifurcated into histology and cytology. On the basis of product, the market is classified into instruments and analysis software system and consumable and reagents. On the basis of test type, the market is divided into microscopy methods, flow cytometry, and molecular genetic methods.

On the basis of application, the market is segregated into drug discovery and designing, clinical diagnostics, and academic research. On the basis of end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. Others include hospital and academic research. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Major key players that operate in the histology and cytology market are Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., Sysmex Corporation, Trivitron Healthcare Private Limited, and Koninklijke Philips N.V.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the histology and cytology market analysis from 2022 to 2032 to identify the prevailing histology and cytology market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the histology and cytology market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global histology and cytology market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
Additional company profiles with specific to client's interest
Expanded list for Company Profiles
Historic market data

Key Market Segments

By Type of Examination

Histology
Cytology

By Product

Instruments and Analysis Software System
Consumable and Reagents

By Test Type

Microscopy Methods
Flow Cytometry
Molecular Genetic Methods

By Application

Drug Discovery and Designing
Clinical Diagnostics
Academic Research

By End User

Pharma and Biotech Companies
CDMO
Diagnostic Laboratories
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Colombia
- Argentina
- Rest of Latin America
Middle East and Africa
- Gcc
- South Africa
- North Africa
- Rest Of Mea

Key Market Players:

Abbott Laboratories
Merck KGaA
Thermo Fisher Scientific, Inc.
Trivitron Healthcare Private Limited
Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Sysmex Corporation
Becton, Dickinson, and Company
Hologic, Inc.

Product Code: A15397

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Low bargaining power of suppliers
- 3.3.2. Low threat of new entrants
- 3.3.3. Low threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. Low bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Growing Pharmaceutical Industry in Asia Pacific Region.
  - 3.4.1.2. Surge in prevalence of chronic diseases.
  - 3.4.1.3. Improving Healthcare Infrastructure.
- 3.4.2. Restraints
  - 3.4.2.1. High cost of histological and cytological analytical instruments.
- 3.4.3. Opportunities
  - 3.4.3.1. Technological advancement in the histological and cytological analysis technology.

CHAPTER 4: HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Histology
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Cytology
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country

CHAPTER 5: HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Instruments and Analysis Software System
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Consumable and Reagents
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country

CHAPTER 6: HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE

6.1. Overview
- 6.1.1. Market size and forecast
6.2. Microscopy Methods
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
6.3. Flow Cytometry
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
6.4. Molecular Genetic Methods
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country

CHAPTER 7: HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION

7.1. Overview
- 7.1.1. Market size and forecast
7.2. Drug Discovery and Designing
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
7.3. Clinical Diagnostics
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
7.4. Academic Research
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country

CHAPTER 8: HISTOLOGY AND CYTOLOGY MARKET, BY END USER

8.1. Overview
- 8.1.1. Market size and forecast
8.2. Pharma and Biotech Companies
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by region
- 8.2.3. Market share analysis by country
8.3. CDMO
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by region
- 8.3.3. Market share analysis by country
8.4. Diagnostic Laboratories
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by region
- 8.4.3. Market share analysis by country
8.5. Others
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by region
- 8.5.3. Market share analysis by country

CHAPTER 9: HISTOLOGY AND CYTOLOGY MARKET, BY REGION

9.1. Overview
- 9.1.1. Market size and forecast By Region
9.2. North America
- 9.2.1. Key market trends, growth factors and opportunities
- 9.2.2. Market size and forecast, by Type of Examination
- 9.2.3. Market size and forecast, by Product
- 9.2.4. Market size and forecast, by Test Type
- 9.2.5. Market size and forecast, by Application
- 9.2.6. Market size and forecast, by End User
- 9.2.7. Market size and forecast, by country
  - 9.2.7.1. U.S.
  - 9.2.7.1.1. Market size and forecast, by Type of Examination
  - 9.2.7.1.2. Market size and forecast, by Product
  - 9.2.7.1.3. Market size and forecast, by Test Type
  - 9.2.7.1.4. Market size and forecast, by Application
  - 9.2.7.1.5. Market size and forecast, by End User
  - 9.2.7.2. Canada
  - 9.2.7.2.1. Market size and forecast, by Type of Examination
  - 9.2.7.2.2. Market size and forecast, by Product
  - 9.2.7.2.3. Market size and forecast, by Test Type
  - 9.2.7.2.4. Market size and forecast, by Application
  - 9.2.7.2.5. Market size and forecast, by End User
  - 9.2.7.3. Mexico
  - 9.2.7.3.1. Market size and forecast, by Type of Examination
  - 9.2.7.3.2. Market size and forecast, by Product
  - 9.2.7.3.3. Market size and forecast, by Test Type
  - 9.2.7.3.4. Market size and forecast, by Application
  - 9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
- 9.3.1. Key market trends, growth factors and opportunities
- 9.3.2. Market size and forecast, by Type of Examination
- 9.3.3. Market size and forecast, by Product
- 9.3.4. Market size and forecast, by Test Type
- 9.3.5. Market size and forecast, by Application
- 9.3.6. Market size and forecast, by End User
- 9.3.7. Market size and forecast, by country
  - 9.3.7.1. Germany
  - 9.3.7.1.1. Market size and forecast, by Type of Examination
  - 9.3.7.1.2. Market size and forecast, by Product
  - 9.3.7.1.3. Market size and forecast, by Test Type
  - 9.3.7.1.4. Market size and forecast, by Application
  - 9.3.7.1.5. Market size and forecast, by End User
  - 9.3.7.2. France
  - 9.3.7.2.1. Market size and forecast, by Type of Examination
  - 9.3.7.2.2. Market size and forecast, by Product
  - 9.3.7.2.3. Market size and forecast, by Test Type
  - 9.3.7.2.4. Market size and forecast, by Application
  - 9.3.7.2.5. Market size and forecast, by End User
  - 9.3.7.3. UK
  - 9.3.7.3.1. Market size and forecast, by Type of Examination
  - 9.3.7.3.2. Market size and forecast, by Product
  - 9.3.7.3.3. Market size and forecast, by Test Type
  - 9.3.7.3.4. Market size and forecast, by Application
  - 9.3.7.3.5. Market size and forecast, by End User
  - 9.3.7.4. Italy
  - 9.3.7.4.1. Market size and forecast, by Type of Examination
  - 9.3.7.4.2. Market size and forecast, by Product
  - 9.3.7.4.3. Market size and forecast, by Test Type
  - 9.3.7.4.4. Market size and forecast, by Application
  - 9.3.7.4.5. Market size and forecast, by End User
  - 9.3.7.5. Spain
  - 9.3.7.5.1. Market size and forecast, by Type of Examination
  - 9.3.7.5.2. Market size and forecast, by Product
  - 9.3.7.5.3. Market size and forecast, by Test Type
  - 9.3.7.5.4. Market size and forecast, by Application
  - 9.3.7.5.5. Market size and forecast, by End User
  - 9.3.7.6. Rest of Europe
  - 9.3.7.6.1. Market size and forecast, by Type of Examination
  - 9.3.7.6.2. Market size and forecast, by Product
  - 9.3.7.6.3. Market size and forecast, by Test Type
  - 9.3.7.6.4. Market size and forecast, by Application
  - 9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
- 9.4.1. Key market trends, growth factors and opportunities
- 9.4.2. Market size and forecast, by Type of Examination
- 9.4.3. Market size and forecast, by Product
- 9.4.4. Market size and forecast, by Test Type
- 9.4.5. Market size and forecast, by Application
- 9.4.6. Market size and forecast, by End User
- 9.4.7. Market size and forecast, by country
  - 9.4.7.1. Japan
  - 9.4.7.1.1. Market size and forecast, by Type of Examination
  - 9.4.7.1.2. Market size and forecast, by Product
  - 9.4.7.1.3. Market size and forecast, by Test Type
  - 9.4.7.1.4. Market size and forecast, by Application
  - 9.4.7.1.5. Market size and forecast, by End User
  - 9.4.7.2. China
  - 9.4.7.2.1. Market size and forecast, by Type of Examination
  - 9.4.7.2.2. Market size and forecast, by Product
  - 9.4.7.2.3. Market size and forecast, by Test Type
  - 9.4.7.2.4. Market size and forecast, by Application
  - 9.4.7.2.5. Market size and forecast, by End User
  - 9.4.7.3. India
  - 9.4.7.3.1. Market size and forecast, by Type of Examination
  - 9.4.7.3.2. Market size and forecast, by Product
  - 9.4.7.3.3. Market size and forecast, by Test Type
  - 9.4.7.3.4. Market size and forecast, by Application
  - 9.4.7.3.5. Market size and forecast, by End User
  - 9.4.7.4. Australia
  - 9.4.7.4.1. Market size and forecast, by Type of Examination
  - 9.4.7.4.2. Market size and forecast, by Product
  - 9.4.7.4.3. Market size and forecast, by Test Type
  - 9.4.7.4.4. Market size and forecast, by Application
  - 9.4.7.4.5. Market size and forecast, by End User
  - 9.4.7.5. South Korea
  - 9.4.7.5.1. Market size and forecast, by Type of Examination
  - 9.4.7.5.2. Market size and forecast, by Product
  - 9.4.7.5.3. Market size and forecast, by Test Type
  - 9.4.7.5.4. Market size and forecast, by Application
  - 9.4.7.5.5. Market size and forecast, by End User
  - 9.4.7.6. Rest of Asia-Pacific
  - 9.4.7.6.1. Market size and forecast, by Type of Examination
  - 9.4.7.6.2. Market size and forecast, by Product
  - 9.4.7.6.3. Market size and forecast, by Test Type
  - 9.4.7.6.4. Market size and forecast, by Application
  - 9.4.7.6.5. Market size and forecast, by End User
9.5. Latin America
- 9.5.1. Key market trends, growth factors and opportunities
- 9.5.2. Market size and forecast, by Type of Examination
- 9.5.3. Market size and forecast, by Product
- 9.5.4. Market size and forecast, by Test Type
- 9.5.5. Market size and forecast, by Application
- 9.5.6. Market size and forecast, by End User
- 9.5.7. Market size and forecast, by country
  - 9.5.7.1. Brazil
  - 9.5.7.1.1. Market size and forecast, by Type of Examination
  - 9.5.7.1.2. Market size and forecast, by Product
  - 9.5.7.1.3. Market size and forecast, by Test Type
  - 9.5.7.1.4. Market size and forecast, by Application
  - 9.5.7.1.5. Market size and forecast, by End User
  - 9.5.7.2. Colombia
  - 9.5.7.2.1. Market size and forecast, by Type of Examination
  - 9.5.7.2.2. Market size and forecast, by Product
  - 9.5.7.2.3. Market size and forecast, by Test Type
  - 9.5.7.2.4. Market size and forecast, by Application
  - 9.5.7.2.5. Market size and forecast, by End User
  - 9.5.7.3. Argentina
  - 9.5.7.3.1. Market size and forecast, by Type of Examination
  - 9.5.7.3.2. Market size and forecast, by Product
  - 9.5.7.3.3. Market size and forecast, by Test Type
  - 9.5.7.3.4. Market size and forecast, by Application
  - 9.5.7.3.5. Market size and forecast, by End User
  - 9.5.7.4. Rest of Latin America
  - 9.5.7.4.1. Market size and forecast, by Type of Examination
  - 9.5.7.4.2. Market size and forecast, by Product
  - 9.5.7.4.3. Market size and forecast, by Test Type
  - 9.5.7.4.4. Market size and forecast, by Application
  - 9.5.7.4.5. Market size and forecast, by End User
9.6. Middle East and Africa
- 9.6.1. Key market trends, growth factors and opportunities
- 9.6.2. Market size and forecast, by Type of Examination
- 9.6.3. Market size and forecast, by Product
- 9.6.4. Market size and forecast, by Test Type
- 9.6.5. Market size and forecast, by Application
- 9.6.6. Market size and forecast, by End User
- 9.6.7. Market size and forecast, by country
  - 9.6.7.1. Gcc
  - 9.6.7.1.1. Market size and forecast, by Type of Examination
  - 9.6.7.1.2. Market size and forecast, by Product
  - 9.6.7.1.3. Market size and forecast, by Test Type
  - 9.6.7.1.4. Market size and forecast, by Application
  - 9.6.7.1.5. Market size and forecast, by End User
  - 9.6.7.2. South Africa
  - 9.6.7.2.1. Market size and forecast, by Type of Examination
  - 9.6.7.2.2. Market size and forecast, by Product
  - 9.6.7.2.3. Market size and forecast, by Test Type
  - 9.6.7.2.4. Market size and forecast, by Application
  - 9.6.7.2.5. Market size and forecast, by End User
  - 9.6.7.3. North Africa
  - 9.6.7.3.1. Market size and forecast, by Type of Examination
  - 9.6.7.3.2. Market size and forecast, by Product
  - 9.6.7.3.3. Market size and forecast, by Test Type
  - 9.6.7.3.4. Market size and forecast, by Application
  - 9.6.7.3.5. Market size and forecast, by End User
  - 9.6.7.4. Rest Of Mea
  - 9.6.7.4.1. Market size and forecast, by Type of Examination
  - 9.6.7.4.2. Market size and forecast, by Product
  - 9.6.7.4.3. Market size and forecast, by Test Type
  - 9.6.7.4.4. Market size and forecast, by Application
  - 9.6.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

11.1. Hologic, Inc.
- 11.1.1. Company overview
- 11.1.2. Key executives
- 11.1.3. Company snapshot
- 11.1.4. Operating business segments
- 11.1.5. Product portfolio
- 11.1.6. Business performance
11.2. F. Hoffmann-La Roche Ltd.
- 11.2.1. Company overview
- 11.2.2. Key executives
- 11.2.3. Company snapshot
- 11.2.4. Operating business segments
- 11.2.5. Product portfolio
- 11.2.6. Business performance
- 11.2.7. Key strategic moves and developments
11.3. Abbott Laboratories
- 11.3.1. Company overview
- 11.3.2. Key executives
- 11.3.3. Company snapshot
- 11.3.4. Operating business segments
- 11.3.5. Product portfolio
- 11.3.6. Business performance
11.4. Becton, Dickinson, and Company
- 11.4.1. Company overview
- 11.4.2. Key executives
- 11.4.3. Company snapshot
- 11.4.4. Operating business segments
- 11.4.5. Product portfolio
- 11.4.6. Business performance
- 11.4.7. Key strategic moves and developments
11.5. Danaher Corporation
- 11.5.1. Company overview
- 11.5.2. Key executives
- 11.5.3. Company snapshot
- 11.5.4. Operating business segments
- 11.5.5. Product portfolio
- 11.5.6. Business performance
11.6. Merck KGaA
- 11.6.1. Company overview
- 11.6.2. Key executives
- 11.6.3. Company snapshot
- 11.6.4. Operating business segments
- 11.6.5. Product portfolio
- 11.6.6. Business performance
11.7. Thermo Fisher Scientific, Inc.
- 11.7.1. Company overview
- 11.7.2. Key executives
- 11.7.3. Company snapshot
- 11.7.4. Operating business segments
- 11.7.5. Product portfolio
- 11.7.6. Business performance
11.8. Sysmex Corporation
- 11.8.1. Company overview
- 11.8.2. Key executives
- 11.8.3. Company snapshot
- 11.8.4. Operating business segments
- 11.8.5. Product portfolio
- 11.8.6. Business performance
11.9. Trivitron Healthcare Private Limited
- 11.9.1. Company overview
- 11.9.2. Key executives
- 11.9.3. Company snapshot
- 11.9.4. Operating business segments
- 11.9.5. Product portfolio
11.10. Koninklijke Philips N.V.
- 11.10.1. Company overview
- 11.10.2. Key executives
- 11.10.3. Company snapshot
- 11.10.4. Operating business segments
- 11.10.5. Product portfolio
- 11.10.6. Business performance